Sample 5011SP5 Accounting for Management M Report

5011SP5 Accounting for Management M Report Sample

Learning Objectives addressed in this assessment:

CO1: Apply basic accounting principles and concepts to understand what accounting information is, what it means and how it is used;

CO2: Explain the significance of accounting information in the business environment;

CO3: Read and interpret financial reports and apply knowledge to critically analyse corporate financial and non-financial information.

Graduate Qualities developed by this assessment:

GQ1: You need to operate effectively upon fundamental accounting practical knowledge;

GQ2: You are prepared for lifelong learning and professional practice;

GQ3: You are working to be an effective business-related problem solver;

GQ4: You can work autonomously and independently;

GQ5: You are committed to ethical action & social responsibility for business activities.

GQ6: You can communicate effectively in written language.

This assessment involves 2 (two) parts: (1) a Written Business Consultation Report (80%); (2) an Oral Presentation of your Consultation Report to Company A (20%). Your total marks for this assessment will be based on the successful completion of both tasks.

This assessment can be completed individually, or in a group of no more than two students (These two students must enrol in the same class to complete the oral task together).

Required:

Write a consultation report for CSL Limited

(1) Choose CSL, a pharmaceutical company from the list of Selected ASX Listed

Pharmaceutical Companies, which is provided as a separate file under Assignment on the course website. One company will be CSL Limited (ASX: CSL) (that has been specified earlier) and the other will be used as a benchmark for analysis against CSL Limited.

Note: If you cannot find an appropriate company when following the above selection rules, you may randomly select a company from the list. However, you need to clearly state the reason for the selection you make in your assignment.

(2) After selecting the two companies, go to the company information database DatAnalysis

Premium via the UniSA Library website. Under Company Reports, search for the companies you selected according to their ASX Codes or part of the company's names. Next, go to Financial Data to review these companies’ financial statements for the financial years from 2020 to 2022 (should 2022 data are not available for the company chosen, you can use data from 2019 to 2021). Hint: Provide a Full Analysis of these Companies’ Financial Ratios across 3 years.

(3) Based on the available data, calculate 3 (three) years (2020-2022) financial ratios of CSL Limited and the selected benchmarking company. Based on these ratio results, analyse and compare the financial performance of these 2 (two) companies. Your calculation and comparative analysis should focus on any 2 (two) of the following four points (explain why you choose these two):

a) Which company is more profitable and generates healthier returns?

b) How well are the two companies managing their resources? Do you think Company A is more efficient in managing its assets compared with the benchmarking company?

c) Can Company A meet its short-term debts? How is its liquidity compared with the bench marking company?

d) Do you think Company A will stay in operation in the long term? How is its long-term financial stability compared with the benchmarking company?

Your answer should be supported by sufficient evidence (i.e. financial statement data and/or ratio results) and analysis. You can also review the annual reports of the two companies for the last three years (Annual Reports are available to download in DatAnalysis Premium), and use the information disclosed in these reports to complement your answers. For example, whether there are issues of concern mentioned in the annual reports that can imply Company A’s financial health and risks and how this might influence your comparative results.

(4) Go to the benchmarking company’s website and investigate whether and how it reports information about sustainability issues, such as carbon emissions, energy consumption, or community contributions, in its annual reports or stand-alone sustainability, CSR (corporate social responsibility), or environmental reports. Do you think Company A should follow what the benchmarking company is doing? Do you support the view that they have performed optimally for its sustainability reporting by Company A, or do you think the company should
prioritise profit growth more? Explain your views.

Solution

Introduction

Rationale for Selected Company

Financial Ratio Analysis

Company Selection

Hydration Pharmaceuticals Company Limited is a consumer product company that sells tablet liquid and powder products in the North American markets of Canada and the United States. For Assignment Help, Healthy Hydrated Solution markets sit in overlaps of over-the-counter medicines, functional vitamins, and mineral and vitamin supplements, which will help, boost health and wellness with a range of rehydrating products.

CSL Limited is an Australian Biotechnology company that develops, manufactures, and conducts research and market products for preventing serious medical human conditions. CSL Limited is considered a global biotechnology company with dynamic portfolios of life-saving medicines for treating immune deficiency and haemophilia, an immune deficiency, and a vaccine for preventing influenza (Csl, 2023).

Rationale for Selected Ratios

In this study, Hydration Pharmaceuticals Company Limited will be chosen as the benchmark company as both companies are multinational companies and these companies have significant changes in their revenue growth in each financial year. Both of these companies are involved in dealing with chemical products and both of the countries have an origin in developed economies.

Financial Analysis of CSL Limited

Liquidity Analysis

The liquidity Ratio for CSL Limited for the years 2020, 2021, and 2022 came at 3.01, 2.38 and 2.51 respectively. In financial markets, investors will conduct investment discussions with the level of risk perception and available information and study business trends (Jermsittiparsert et al., 2019).

Profitability Analysis

From the ratio analysis, it can be stated that CSL Limited experienced growth in its profitability while Hydration Pharmaceuticals Company Limited experienced significant losses for the three financial years of 2020, 2021 and 2022. The Cash Ratio of CSL Limited for the financial years 2020, 2021, and 2022 was .55, .58 and 1.4.

Financial Analysis of Hydration Pharmaceuticals Company Limited

Liquidity Analysis

Financial ratio plays a vital role in revealing corporate financial soundness, which helps enterprises maintain their competitive positions achieve stable development and eliminate potential risks (Kliestik et al., 2020). The current ratio is considered the liquidity ratio, which helps to analyze if the firm possesses enough resources to meet its short-term liabilities. It is generating by dividing the total current assets by Current liabilities.
The liquidity ratio of Hydration Pharmaceuticals Company Limited for the years 2020, 2021 and 2022 came at 9.02, 7.43 and 7.4. A current ratio above two implies that the company possesses enough current assets than liabilities for meeting its short-term debt obligation. The current ratio of less than one will imply that the company will face significant difficulty in meeting its debt obligations.

Profitability Analysis

Hydration Pharmaceuticals Company Limited's Current ratio came above 6 for three financial years. It implied that the company possesses enough cash and is more than capable of meeting its debt obligations. The gross profit Margin is calculated by dividing the gross profit by the revenue of the company. In certain situations, due to a sudden decrease in revenue because of external factors company may experience a negative gross profit margin ratio. The Cash Ratio of Hydration Pharmaceuticals Company Limited for 2020, 2021, and 2022 came at 7.2, 5.1 and 5.18 respectively.

The negative gross profit margin ratio of Hydration Pharmaceuticals Company Limited implies that the company has not been able to control its costs of production. From the financial report of Hydration Pharmaceuticals Company Limited, it is found that the company experienced a severe net loss for the financial year and generated a loss per share. The revenue of Hydration Pharmaceuticals Company Limited for the years 2020, 2021, and 2022 came at 6127178$, 3756695$, and 296285$ while the net loss came at 8951661$, 743663$ and 3434151$. The loss per share for 2020, 2021, and 2022 came at .06$, .01$, and .12$ respectively.

Comparative Analysis

Profitability Ratio

Figure 1: Profitability Ratio of CSL Limited
(Source Self-created)

Financial statements include the income statement, balance sheet cash flow statement, and accompanying notes (Brown et al., 2022).From the data obtained from, the financial statements from 2020, 2021, and 2022 of CSL Limited and Hydration Pharmaceuticals Company Limited, it is found that CSL has agreed to health reasons for its sustained growth. Hydration Pharmaceuticals Company Limited has incurred significant losses for the three financial years. CSL Limited was more profitable and generated healthier returns. It also experienced significant growth in its profitability that is considered vital for maintaining the company's sustainable growth. Ratio analysis plays an important role in improving diagnostic accuracy (Pascal et al., 2021). It can be agreed with the fact that Company A (CSL Limited) is more efficient in managing its assets in comparison to Company B (Hydration Pharmaceuticals Company Limited). Even with greater revenue and asset Hydration Pharmaceuticals Company Limited have been unable to conduct effective utilization of its resource to enhance its business performance on the other hand, CSL Limited with less revenue and cash in hand have been able to generate sustainable and healthy profits while conducting its business operation in the three financial years.

Liquidity Ratio

The capital market plays a vital role in meeting the capital needs of the business world for developing and being sustainable (Pattiruhu, 2020). In accordance with the benchmark Company (Hydration Pharmaceuticals Company Limited), it can be stated that the liquidity ratio of the benchmark company is greater than that of CSL Limited. The liquidity ratio of Hydration Pharmaceuticals Company Limited is considered to be greater than 5. In case of meeting short-term debts, Hydration Pharmaceuticals Company Limited will be able to meet its short-term debt obligations while CSL Limited will face significant challenges in meeting its short-term debt obligation as its current ratio is significantly low and it poses significant liabilities in comparison to its assets.

Figure 2: Liquidity Ratio
(Source Self-created)

Pre-components Percentage Analysis is used to compare one account to the total account (Sihombing et al., 2022). From the analysis, it is concluded that Company A will be able to stay in operation in the long term. The Hydration Pharmaceuticals Company Limited has experienced significant losses over the three consequent years. The company was experiencing yearly losses while CSL Limited will be able to stay in operation for the longer term as the company was experiencing more than 10% revenue growth in each financial year. Hydration Pharmaceuticals Company Limited is experiencing a steep decline in its revenues and is experiencing severe losses so it will be significantly challenging the company to sustain in the longer run.

Figure 3: Quick Ratio of Hydration Pharmaceuticals Company Limited
(Source Self-created)

Sustainability Reporting Initiatives

Corporate Social responsibility is considered as a management concept where companies integrate environmental and social concerns in their business operations and interactions with stakeholders. The emission of greenhouse gasses from the combustion of fossil fuel is related to the earth's climate warming and air pollutants, contribute to global warming. CSR is significantly generalized in categories like environmental responsibility, human responsibility, and economic responsibility. It helps companies build credibility and trust with their stakeholders. Hydration Pharmaceuticals Company Limited’s environmental and social issues are reported in its financial statements. The annual financial statement implies that the company operations are not regulated by any kind of environmental regulations under any kind of commonwealth law. Long-term incentives is intended to reward executives’ sustainable long-term growth. It is aligned with shareholder interests. Hydration Pharmaceuticals Company Limited is required to allocate a significant percentage of its net profits towards corporate social responsibility activities. It manufactures rehydration electrolyte products and the company educates the causes of management.

Should CSL Follow the Same

Company A (CSL Limited) should not be following Company B (Hydration Pharmaceuticals Company Limited) in reducing its environmental emissions. The key energy sources of CSL manufacturing factories are considered as natural gas and electricity (Csl, 2023). In CSL plasma network centers electricity is the main source of energy. Combined manufacturing and CSL plasma Centre have significantly contributed to MOT of CSL energy Consumption and greenhouse emissions. As part of its sustainability strategy, CSL has adopted for sustainable future for employees, patients, and communities. CSL announced Carbon emissions that serves as a transparent roadmap for decarbonizing global operations by cutting down carbon emissions. CSL announced the building of cell-based influenza vaccines CSL proprietary and Q fever vaccine. CSL facilities will help implement onsite renewable energy generation, electrification to reduce reliance on natural gas, reclaiming water reuse, and heat recovery for the waste management process.

In the year 2020, CSL Limited announced its first emission reduction targets. Based on its targets, CSL Limited has committed to a 40% reduction in Scope 1 and Scope 2 emissions by the year 2030 using the averages of CSL's FY19-21 emissions as the basis (Csl, 2023). CSL has announced them by the year 2023 it seeks to reduce emissions, which is associated with its operation, and ensure suppliers will contribute 67% per cent of Scope 3 Emissions are associated with science-based target initiatives and CSL targets are being aligned to limit global warming to 1.5 degrees Celsius. In addition to climate resilience, emission reduction and energy are considered as key components in CSKL corporate sustainability strategies and are committed to proactively adapting and mitigating climate changes. CSL supports the use of proper mechanisms for addressing climate change, which are consistent with international approaches and are designed to encourage investment and innovation in GHG emission mitigation technologies while also limiting adverse effects on national economies.

Sustainability Reporting by CSL Limited

Company A (CSL limited) should implement its sustainability initiatives as the world is moving towards an eco-friendly approach it will help in maintaining the company's sustainable growth in the long run. CSL Limited's commitment to a healthier approach implies delivering to both the planet and its people. CSL Limited seriously takes this responsibility to further maintain environmental considerations in buying which will help in delivering a sustainable world for the next century. CSL Limited recognizes responsible management and efficient use of natural resources that are vital for a company's sustainable growth. CSL Limited recognizes that responsible management and efficient use of natural resources are key to the company's suitable growth and will help in implementing its ability to deliver an effective and reliable supply of life-saving medicines. CSL Limited supports meeting the goals of the Paris Agreement for avoiding the worst climate change impacts that are being identified by the intergovernmental panel on climate change. CSL Limited continues to execute the sustainability strategy for integrating sustainability considerations in business decisions and reducing carbon emissions (CSL, 2023).

Conclusion and Recommendation

To conclude we can state that, the consultancy report of Hydration Pharmaceuticals Company Limited and CSL Limited consultancy report has been prepared. The financial position of the two companies for the three financial years has been analysed to evaluate the financial health of the company. The liquidity ratio and the gross profit margin ratio have been evaluated for three years to evaluate the company's financial performance. Hydration Pharmaceuticals Company Limited has incurred a significant amount of losses in the three financial years of 2020, 2021, and 2022 while CSL Limited has experienced significant growth in its profitability that will help in maintaining its sustainable and healthy growth. In terms of reducing environmental emissions and implementing CSR responsibilities, CSL Limited has a significant edge over Hydration Pharmaceuticals Company Limited. CSL Limited has specific emission reduction targets while operations of Hydration Pharmaceuticals Company Limited are not under the jurisdiction of Commonwealth Law. To improve the business performance CSL Limited and Hydration Pharmaceuticals Company Limited can adopt further clarification of their business plan and adopt a flexible financing structure, which will help in improving their business operations and help in maintaining long-term sustainable growth.

Recommendations

- Evaluating and Clarifying Business Plan :

A business plan is a road map for financial, marketing, operational, and financial standpoints. Hydration Pharmaceuticals Company Limited will have to adopt modern technologies in its cost of production to reduce its operational cost, for the company to be able to experience profitability growth in each financial year. A sustainable business plan is required to be adopted and proper evaluation must be done to deal with the shortcomings. In the case of CSL Limited, the Company has to continue its business operations and avoid acquiring further liabilities or it may face bankruptcy for being unable to meet its debt obligations. Proper experts must be hired to implement an effective business plan that will help in maintaining sustainable growth of the company and maintain environmental ethics while continuing its business operations.

- Adopting Flexible Financing Structure

Financing structure refers to the mix of equity and debt, which are used by a company to finance its operations. Hydration Pharmaceuticals Company Limited has to implement asset utilization to increase its revenue generation and reduce its operational costs. For example, the company may allocate some jobs to ex-employees with expertise, which will significantly improve the quality of the output. Employees can be provided with flexible working hours to increase their productivity. In the case of CSL Limited, the company must focus on reducing its liabilities and implement debt restructuring so that it will not affect its business operations. It will help CSL Limited to avoid the chances of bankruptcy and avoid being sued for debt.

Reference list